UNSPSC 51141561: Ezogabine or retigabine

This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 12G01I6BBU. European Medicines Agency schedules Retigabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10291MIG. Ezogabine generally arises in the molecular formula C16H18FN3O2. The term 'ezogabine' is a European Medicines Agency European Public Assessment Report System designation. Ezogabine or retigabine bears US NLM identifiers UMLS ID C0530684 and NCI Concept Code C72839.

SMILES: FC1CCC(CNC2CC(N)C(NC(=O)OCC)CC2)CC1.

UNSPSC 51141561 Ezogabine or retigabine is a Commodity code with no recent state and local procurement activity aligned to its nominal scope. The three most recent opportunities posted under this code—a Seminole County IFB for naloxone and drug deactivation systems, a Texas HHS RFI for direct-to-manufacturer prescription programs, and an MMCAP RFP for generic multi-source pharmaceuticals and OTC products—are pharmaceutical procurement activities that do not match the specific anticonvulsant medication named in the code. State and local government procurement tagging does not always align classifications precisely with actual commodity content, and the wide disparity between the code's narrow product definition and the broad pharmaceutical supply categories appearing in recent notices suggests either classification drift or inconsistent code assignment by issuing bodies.

Geographic activity spans Florida, Texas, and Minnesota, with the MMCAP cooperative purchasing vehicle serving multiple states including Oregon. Issuing bodies include a county health department, a state health and human services commission, and a multistate cooperative purchasing alliance administered through a state department of administration. Without solicitations specifically targeting ezogabine or retigabine as a line item, the code presents limited opportunity targeting for vendors focused on that particular pharmaceutical. Professionals evaluating this code should verify whether state and local buyers are actually sourcing this medication through direct pharmaceutical-supply RFPs or through broader generic-drug cooperative contracts, as the current classification tag does not surface relevant activity.